5 commercial payer policies list J2998. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
5 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of J2998 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Ryplazim (Plasminogen, Human-Tvmh) | Mar 1, 2026 | Covered |
| Policy | Effective | Status of J2998 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Ryplazim (Plasminogen, Human-Tvmh) | Mar 1, 2026 | Covered |
| Policy | Effective | Status of J2998 |
|---|---|---|
| Ryplazim (Plasminogen, Human-Tvmh) | Mar 1, 2026 | Covered |